PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141 (Bremelanotide): Research Applications and Quality Assessment

Bremelanotide, also known as PT-141, is a synthetic melanocortin receptor agonist being investigated for its potential effects on sexual dysfunction. Unlike Viagra and other PDE5 inhibitors that act on the vascular system, bremelanotide directly influences the central nervous system, specifically targeting melanocortin receptors believed to be involved in sexual arousal. This article provides a comprehensive overview of PT-141, its mechanism of action, research applications, crucial quality markers, common impurities, storage requirements, and practical guidance for researchers aiming to incorporate this peptide into their studies.

Molecular Structure and Properties

PT-141 is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (?-MSH). Its amino acid sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. The cyclization is achieved through a lactam bridge between the Asp and Lys residues. The molecular weight is approximately 1025.2 Da, and its molecular formula is C50H68N14O10. The presence of non-natural amino acids like Norleucine (Nle) and D-Phenylalanine (D-Phe) enhances its metabolic stability and receptor binding affinity compared to the native ?-MSH peptide.

Mechanism of Action

Bremelanotide exerts its effects by binding to and activating melanocortin receptors, primarily MC1R and MC4R. While MC1R is mainly associated with pigmentation, MC4R is implicated in various physiological processes, including sexual function, energy homeostasis, and inflammation. The primary target for bremelanotide's aphrodisiac effects is believed to be MC4R in the central nervous system. Activation of MC4R by bremelanotide leads to increased sexual desire and arousal through complex neuroendocrine pathways that are still being actively researched. Unlike PDE5 inhibitors, bremelanotide does not directly affect blood flow to the genitals, suggesting a more central mechanism of action.

Research Applications

PT-141 is currently being investigated in research settings for a variety of potential applications, primarily related to sexual dysfunction.

• Female Sexual Dysfunction (FSD): The most prominent area of research involves the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Studies are evaluating the efficacy and safety of bremelanotide in improving sexual desire, reducing distress associated with low sexual desire, and increasing the frequency of satisfying sexual events.
• Male Erectile Dysfunction (ED): Although less extensively studied than in women, PT-141 is also being investigated for its potential to treat ED, particularly in cases where PDE5 inhibitors are ineffective or contraindicated. Its central mechanism of action offers a potential alternative for men who do not respond to traditional treatments.
• Other Potential Applications: Preliminary research suggests that melanocortin receptor agonists like PT-141 may have potential applications in other areas, including:
  • Treatment of Obesity: MC4R activation is known to play a role in energy homeostasis.
  • Management of Inflammatory Conditions: Some studies suggest a potential anti-inflammatory effect mediated by melanocortin receptors.
  • Treatment of Melanoma: MC1R is a target for melanoma research.

Quality Markers for PT-141

Ensuring the quality of PT-141 is paramount for obtaining reliable and reproducible research results. Several key quality markers should be carefully evaluated when sourcing and using this peptide.

Peptide Purity

Purity refers to the percentage of the peptide in the sample that is actually the desired PT-141 sequence. A high level of purity is essential to minimize the presence of unwanted byproducts and degradation products that could interfere with experimental results. Purity is typically determined by analytical High-Performance Liquid Chromatography (HPLC).

• HPLC Analysis: Reversed-phase HPLC (RP-HPLC) is the standard method for determining peptide purity. The peptide sample is separated based on hydrophobicity, and the area under the peak corresponding to PT-141 is compared to the total area of all peaks.
• Purity Acceptance Criteria: For research purposes, a purity level of at least 95% is generally recommended. Some highly sensitive applications may require even higher purity levels (e.g., >98%).
• Certificate of Analysis (CoA): Always request a CoA from the supplier that includes the HPLC chromatogram and the reported purity value. Carefully examine the chromatogram for the presence of any significant impurity peaks.

Peptide Identity

Confirming the identity of the peptide is crucial to ensure that the correct sequence has been synthesized. Mass spectrometry (MS) is the primary technique used to verify peptide identity.

• Mass Spectrometry (MS): MS measures the mass-to-charge ratio of ions, allowing for the determination of the peptide's molecular weight. The measured molecular weight should match the theoretical molecular weight of PT-141 (1025.2 Da) within a narrow tolerance (e.g., ± 0.5 Da). Tandem mass spectrometry (MS/MS) can provide further confirmation by fragmenting the peptide and analyzing the resulting fragment ions.
• Amino Acid Analysis (AAA): Although less commonly used for routine quality control, AAA can be used to determine the amino acid composition of the peptide. The measured amino acid ratios should correspond to the expected ratios based on the PT-141 sequence.
• Certificate of Analysis (CoA): The CoA should include MS data confirming the correct molecular weight. Ideally, it should also include a sequence coverage map from MS/MS analysis.

Peptide Content

Peptide content refers to the actual amount of PT-141 present in the sample, taking into account factors such as residual water content, salt content, and counterions. This is typically expressed as a percentage.

• Quantitative Amino Acid Analysis (qAAA): This is the gold standard for determining peptide content. The peptide is hydrolyzed into its constituent amino acids, which are then quantified using HPLC. This provides a precise measurement of the peptide content.
• Nitrogen Determination (Kjeldahl Method): This method measures the total nitrogen content of the sample, which can be used to estimate the peptide content. However, this method is less specific than qAAA, as it does not distinguish between peptide nitrogen and nitrogen from other sources.
• UV Spectrophotometry: If the peptide contains a chromophore (e.g., tryptophan), UV spectrophotometry can be used to estimate the peptide content. However, this method requires accurate knowledge of the peptide's extinction coefficient.
• Importance of Content: Knowing the peptide content is essential for accurately preparing solutions and dosing in research studies. A peptide with a reported purity of 95% but a content of only 80% will require a significant adjustment in the amount weighed out to achieve the desired concentration.

Water Content

Peptides are hygroscopic and can absorb water from the atmosphere. Excessive water content can affect the accuracy of weighing and dosing and can also contribute to peptide degradation.

• Karl Fischer Titration: This is the standard method for determining water content. The water content should ideally be below 5%.
• Impact on Dosing: The water content should be taken into account when calculating the amount of peptide to weigh out for preparing solutions.

Counterions

During peptide synthesis and purification, counterions (e.g., trifluoroacetate, acetate, hydrochloride) are often added to improve solubility and stability. The presence of counterions can affect the overall weight of the peptide and should be considered when preparing solutions.

• Ion Chromatography: This technique can be used to identify and quantify the counterions present in the peptide sample.
• Supplier Information: The supplier should provide information about the counterions present in the peptide and their approximate percentage.
• Impact on Dosing: The presence of counterions needs to be factored in when calculating the mass of peptide needed to achieve a specific molar concentration.

Endotoxin Levels

Endotoxins are lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria. Even trace amounts of endotoxins can elicit a strong immune response in vivo and can interfere with cell culture experiments.

• Limulus Amebocyte Lysate (LAL) Assay: This is the standard method for detecting and quantifying endotoxins.
• Acceptance Criteria: For in vivo studies and cell culture experiments, the endotoxin level should be below 10 EU/mg (Endotoxin Units per milligram) of peptide. Lower levels may be required for highly sensitive applications.

Common Impurities in PT-141

Several types of impurities can be present in synthetic peptides. Understanding these impurities is crucial for interpreting experimental results and ensuring the reliability of research findings.

• Deletion Sequences: These are peptide sequences missing one or more amino acids. They arise from incomplete coupling during peptide synthesis.
• Truncated Sequences: These are peptide sequences that are prematurely terminated during synthesis.
• Modified Amino Acids: Amino acids can undergo various modifications during synthesis, such as oxidation, racemization, or incomplete deprotection.
• Diastereomers: The presence of D-amino acids (especially D-Phe) necessitates careful control during synthesis to minimize the formation of diastereomers.
• Protecting Group Derivatives: Incomplete removal of protecting groups used during peptide synthesis can lead to the presence of protected peptide derivatives.
• Solvents and Reagents: Residual solvents and reagents used during synthesis and purification can be present in the final product.
• Degradation Products: Peptides can degrade over time, especially under unfavorable storage conditions. Degradation products can include hydrolyzed peptide fragments, oxidized amino acids, and aggregated peptides.

Practical Tip: Request a detailed impurity profile from the supplier, including information about the identity and quantity of any known impurities. This information can be helpful for interpreting experimental results and troubleshooting any unexpected findings.

Storage Requirements for PT-141

Proper storage is essential to maintain the integrity and stability of PT-141. Following these guidelines will help to minimize degradation and ensure the long-term viability of the peptide.

• Temperature: Store PT-141 at -20°C or -80°C in a freezer. Avoid repeated freeze-thaw cycles, as this can lead to peptide degradation. Aliquot the peptide into smaller portions to minimize the number of freeze-thaw cycles.
• Desiccation: Store the peptide in a tightly sealed container with a desiccant to protect it from moisture.
• Light Protection: Protect the peptide from light by storing it in a dark container or wrapping it in aluminum foil.
• Solvent: If storing in solution, use a solvent appropriate for PT-141 and its intended use. Common solvents include sterile water, saline, or DMSO. The choice of solvent can impact the stability of the peptide.
• pH: The optimal pH for peptide stability varies depending on the specific peptide sequence. For PT-141, a slightly acidic pH (e.g., pH 5-6) may be beneficial. Consider buffering the solution to maintain a stable pH.
• Storage Time: Lyophilized PT-141 can typically be stored for several years at -20°C or -80°C. However, once reconstituted in solution, the peptide is more susceptible to degradation and should be used within a shorter timeframe (e.g., days or weeks), depending on the storage conditions and the concentration of the solution.

Sourcing Considerations

Selecting a reputable supplier is crucial for obtaining high-quality PT-141. Consider the following factors when choosing a supplier:

• Reputation and Experience: Choose a supplier with a proven track record of producing high-quality peptides.
• Manufacturing Standards: Ensure that the supplier adheres to good manufacturing practices (GMP) or ISO standards.
• Quality Control Procedures: Inquire about the supplier's quality control procedures and the analytical methods used to assess peptide purity, identity, and content.
• Certificate of Analysis (CoA): Always request a CoA for each batch of peptide. Carefully review the CoA to ensure that the peptide meets your quality requirements.
• Customer Support: Choose a supplier that provides excellent customer support and is responsive to your questions and concerns.
• Price: While price is a factor, it should not be the sole determinant. Prioritize quality and reliability over the lowest price. A lower price may indicate lower quality or compromised manufacturing practices.

Key Takeaways

• PT-141 (Bremelanotide) is a melanocortin receptor agonist under investigation for sexual dysfunction.
• It acts centrally, targeting MC4R in the brain, offering a different mechanism than PDE5 inhibitors.
• Purity (?95% by HPLC) and confirmed identity (by MS) are critical quality markers.
• Quantitative amino acid analysis (qAAA) is the gold standard for determining peptide content.
• Store lyophilized PT-141 at -20°C or -80°C, protected from moisture and light, and avoid freeze-thaw cycles.
• Request a Certificate of Analysis (CoA) from the supplier and carefully review it for all quality markers.
• Consider endotoxin levels, especially for in vivo or cell culture studies.
• Choose a reputable supplier with a proven track record and robust quality control procedures.